PAA 5.26% 20.0¢ pharmaust limited

Ann: Motor Neurone Disease Phase 1/2 Clinical Trial Update, page-166

  1. 2,706 Posts.
    lightbulb Created with Sketch. 1482
    A commercial outcome, or certainty of one.

    The way this board communicates and behaves sows a lot of doubt. The only thing that will create the demand you talk of is when we are registering for a specific use and we are likely to become a standard of care.

    Everything else is just more talk from a board who have proven time and again they are totally unreliable.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
20.0¢
Change
0.010(5.26%)
Mkt cap ! $97.28M
Open High Low Value Volume
19.0¢ 20.5¢ 19.0¢ $326.8K 1.645M

Buyers (Bids)

No. Vol. Price($)
5 138704 20.0¢
 

Sellers (Offers)

Price($) Vol. No.
20.5¢ 60000 1
View Market Depth
Last trade - 16.10pm 25/09/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.